Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Stephen McMillan Files to Sell 10,000 Teradata Shares

Teradata Corporation director and officer Stephen McMillan filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 10,000 shares of Teradata common stock on the New York Stock Exchange.

Manish Choudhary | 09 November 2026

Breen Exercises 89,845 DuPont Options, Sells Same Day

Director Edward D. Breen filed a Form 4 with the SEC on November 9, 2026, disclosing a same-day exercise and sale of 89,845 stock options in DuPont de Nemours, Inc. (NYSE:DD) on November 5, 2026, along with a prior grantor retained annuity trust transaction …

Anjali Anand | 09 November 2026

DuPont CEO Lori Koch Exercises 2,311 Options, Sells Shares Nov. 9

DuPont de Nemours, Inc. CEO and Director Lori Koch filed a Form 4 on November 9, 2026, disclosing the exercise of 2,311 stock options and the same-day sale of 2,311 shares of common stock.

Vinay Lochav | 09 November 2026

DuPont SVP Hoover Exercises 4,203 Options, Sells Shares

Erik T. Hoover, SVP and General Counsel of DuPont de Nemours, Inc., filed a Form 4 on November 9, 2026, disclosing the exercise of stock options and the same-day sale of 4,203 shares of common stock.

Aditi Sarkar | 09 November 2026

DuPont Officer Hoover Files to Sell 4,203 Shares via Option Exercise

DuPont de Nemours, Inc. officer Erik T. Hoover filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 4,203 shares of common stock acquired through the exercise of employee stock options.

Shwetambri Chauhan | 09 November 2026

Justin Klee Plans to Sell 100,000 Amylyx Shares

Amylyx Pharmaceuticals, Inc. director and officer Justin Klee filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 100,000 shares of common stock through Morgan Stanley Smith Barney LLC.

Vinay Lochav | 09 November 2026

Lori Koch Plans to Sell 2,311 DuPont Shares via Option Exercise

DuPont de Nemours, Inc. officer Lori Koch filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 2,311 shares of common stock to be acquired through a broker-assisted cashless exercise of employee stock options on the same date.

Vinay Lochav | 09 November 2026

Amylyx Officer Frates Plans 40,000-Share Option Sale

James M. Frates, an officer of Amylyx Pharmaceuticals, Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 40,000 shares of common stock to be acquired through the exercise of stock options.

Vinay Lochav | 09 November 2026

Joshua Cohen Plans to Sell 100,000 Amylyx Shares

Director and Officer Joshua Barry Cohen filed a Form 144 notice of proposed sale of 100,000 shares of Amylyx Pharmaceuticals Inc common stock on November 9, 2026, pursuant to Rule 144 under the Securities Act of 1933.

Shwetambri Chauhan | 09 November 2026

First Horizon Officer Bryan Plans 100,932-Share Sale

An amended Form 144 notice of proposed sale was filed on November 9, 2026, disclosing that First Horizon Corp officer and director Jordan D. Bryan intends to sell 100,932 shares of common stock through Fidelity Brokerage Services LLC.

Manish Choudhary | 09 November 2026
Support

Hi! How can we help you today?

Loading…